Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.08 USD
Change Today 0.00 / 0.00%
Volume 38.4K
BOTA On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geoffrey F. Cox Ph.D., BSc

Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee,Biota Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 127 board members in 6 different organizations across 7 different industries.

See Board Relationships


Dr. Geoffrey F. Cox, Ph.D., BSc has been an Interim Chief Executive Officer of QLT Inc. since October 23, 2014. Dr. Cox serves as a Partner at Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors. Dr. Cox served as Chairman, Chief Executive Officer and President of rEVO Biologics (formerly, GTC Biotherapeutics Inc.) from July 2001 to June 15, 2010. Dr. Cox served as the ...

Read Full Background

Corporate Headquarters*

2500 Northwinds Parkway
Alpharetta, Georgia 30009

United States

Phone: 678-221-3343
Fax: --

Board Members Memberships*

Non-Executive Director
Independent Director
Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Interim Chief Executive Officer and Director


University of Birmingham
University of East Anglia

Other Affiliations*

Annual Compensation*

Total Annual Compensation$94,398

Stock Options*

Exercisable Options61,806
Exercisable Options Value$7,472
Unexercisable Options113,194
Unexercisable Options Value$14,528
Total Value of Options$22,000
Total Number of Options175,000

Total Compensation*

Total Annual Cash Compensation$187,297
Total Short Term Compensation$94,398
Total Calculated Compensation$475,262
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOTA:US $2.08 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at